Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Long-Term Deferred Tax (2017 - 2018)

Lisata Therapeutics (LSTA) has disclosed Long-Term Deferred Tax for 4 consecutive years, with $575055.0 as the latest value for Q1 2018.

  • For the quarter ending Q1 2018, Long-Term Deferred Tax changed N/A year-over-year to $575055.0, compared with a TTM value of $575055.0 through Mar 2018, changed N/A, and an annual FY2017 reading of $575000.0, changed N/A over the prior year.
  • Long-Term Deferred Tax was $575055.0 for Q1 2018 at Lisata Therapeutics, roughly flat from $575000.0 in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $575055.0 in Q1 2018 and bottomed at $575000.0 in Q4 2017.